ArticleAmerican journal of cancer research2022

Combined inhibition of FGFR4 and VEGFR signaling enhances efficacy in FGF19 driven hepatocellular carcinoma.

Xuesong Zhao et al.PubMed ↗Full text ↗

No numbers read from the abstract.